Daily Stock Analysis, CTMX, CytomX Therapeutics Inc, priceseries

CytomX Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
5.52
Close
5.50
High
5.74
Low
5.50
Previous Close
5.59
Daily Price Gain
-0.09
YTD High
19.75
YTD High Date
Feb 5, 2019
YTD Low
5.38
YTD Low Date
Nov 11, 2019
YTD Price Change
-10.12
YTD Gain
-64.79%
52 Week High
19.75
52 Week High Date
Feb 5, 2019
52 Week Low
5.38
52 Week Low Date
Nov 11, 2019
52 Week Price Change
-8.76
52 Week Gain
-61.43%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 27. 2017
12.31
Mar 7. 2017
13.12
6 Trading Days
6.62%
Link
LONG
Mar 16. 2017
15.00
Mar 29. 2017
16.52
9 Trading Days
10.12%
Link
LONG
Aug 22. 2017
14.76
Sep 12. 2017
16.74
14 Trading Days
13.40%
Link
LONG
Sep 27. 2017
17.92
Oct 16. 2017
20.55
13 Trading Days
14.70%
Link
LONG
Jan 3. 2018
22.39
Feb 5. 2018
26.08
22 Trading Days
16.47%
Link
LONG
Feb 21. 2018
28.02
Mar 20. 2018
32.64
19 Trading Days
16.48%
Link
LONG
Jan 30. 2019
16.74
Feb 14. 2019
18.21
11 Trading Days
8.79%
Link
Company Information
Stock Symbol
CTMX
Exchange
NasdaqGS
Company URL
http://www.cytomx.com
Company Phone
650.515.3185
CEO
Sean A. McCarthy
Headquarters
California
Business Address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA 94080
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001501989
About

CytomX Therapeutics, Inc. operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer. The company was founded in September, 2010 and is headquartered in South San Francisco, CA.

Description

Preclinical biotech developing tumor-activated cancer immunotherapies.